Are GLP-1 Drugs Dangerous? A UK Safety Guide (October 2026)

01 · The core answer

Are GLP-1 drugs dangerous to take?

No licensed GLP-1 medicine is classed as dangerous when it is prescribed appropriately, but every one carries side effects and some people should not use them. The patient leaflet sets out the details and is worth reading in full.¹³

Headlines tend to flatten two different questions. The first is whether a regulated medicine, used as licensed, carries acceptable risk for a suitable patient. The second is whether it is safe for anyone, in any form, from any seller. The honest answers differ. If you want a medicine-specific view, our guides on whether Mounjaro is dangerous to take and whether weight loss drugs are dangerous go further.

02 · What to do next

The decision you are actually facing

Your real choice is whether a supervised, licensed treatment is right for you given your own health history. That is a clinical judgement, not a verdict from a headline or a forum thread.

Mounjaro (tirzepatide) is licensed in the UK for weight management in adults and for type 2 diabetes.¹ It is used alongside a reduced-calorie diet and increased physical activity.¹ If you are ready to see whether you qualify, you can start a free consultation for the Mounjaro pen, where a GPhC-registered prescriber reviews your answers before anything is dispensed.

For a wider look at the topic, see our weight loss clinic overview.

Related guide: Is mounjaro dangerous to take for weight loss.

03 · Known side effects

What are the worst side effects of GLP-1 medicines?

The patient information leaflet separates common effects from rare but serious ones.¹³ The most common effects, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort. Side effects are most likely when starting treatment or moving up a dose, and for most people they ease within days to a few weeks as the body adjusts.

Tirzepatide activates the GIP and GLP-1 receptors, which help regulate appetite and slow how quickly the stomach empties.¹ That is why the digestive system is where many people notice the medicine first, and why prescribers review how you are coping as the dose changes.

If you notice a new or lasting symptom, tell your prescriber. For severe symptoms, get medical help straight away. You can also report suspected side effects through the Yellow Card scheme.¹⁹ Reports help regulators spot patterns.

04 · Brain and mental health

What do GLP-1 drugs do to your brain, and what about mental side effects?

These medicines act on appetite signalling, and regulators have examined mental health questions directly. Regulators have looked specifically at whether GLP-1 medicines are linked to low mood or suicidal thoughts: the EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link, and the MHRA keeps this under continuous review.¹⁷

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

Tell your prescriber about any history of depression, and seek help promptly if your mood drops or you have distressing thoughts during treatment. Tell your prescriber about any new anxiety, low mood or unusual thoughts, and report them through the Yellow Card scheme.¹⁹

05 · Who should be careful

Who needs extra caution?

People with certain medical histories, those taking other medicines, and anyone pregnant or planning pregnancy need individual advice before starting. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. You should not take Mounjaro if you are allergic to tirzepatide or any of its ingredients, and your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. This is why a consultation matters more than the product itself.

Eligibility is also a safety filter. Our own prescriber reviews health answers against the licence, and unsuitable orders are refunded automatically.

Take particular care to check suitability if you are already at a healthy weight and want to lose a little. The licence and the evidence are built around adults with overweight or obesity, so ask a prescriber whether treatment is appropriate rather than assuming it is.¹

06 · Is it worth the risk?

Is taking a GLP-1 worth the risk?

That depends on what the treatment may do for you and on your own risk profile. On the benefit side, in the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

Weigh that against the side effects in the leaflet, the commitment to regular injections and the need for follow-up. Your GP or prescriber is the right person to weigh your heart and metabolic health.

Read the leaflet first, tell the prescriber everything, expect to need support during dose changes, and know how to reach your pharmacy team.

07 · Real danger: unregulated supply

The danger that is avoidable

The clearest danger is buying from sellers who supply without a consultation or prescription. You cannot know what is in the vial or pen, how it was stored or whether it is genuine. The MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme for exactly this reason.⁷

Check any pharmacy on the public GPhC register before ordering. We are registered under GPhC 9012878, and Mounjaro comes through official LillyDirect supply direct from Eli Lilly's UK distribution as genuine KwikPens.¹²

The related questions about whether GLP1 is dangerous and what counts as a GLP-1 are worth reading if you are comparing options, and some people ask whether products such as Semglee count as a GLP-1.

08 · Stopping and aftercare

What happens if you stop, and who supports you?

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.

Safe use is an ongoing process, not a one-off purchase. With us, aftercare includes monthly reviews, dose titration and follow-up assessments by the prescribing team, plus side-effect support. Repeat orders re-check suitability and nothing ships automatically. Needles, a sharps bin and injection guidance come with every order.

09 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹